Top Abstract Purchase Related
Home
>
Node
>
Subnode

18-Fluorodeoxyglucose imaging in oncology

Harolds, J.A.

Journal of the Oklahoma State Medical Association 92(9): 457-461

1999

ISSN/ISBN: 0030-1876
PMID: 10504797
Document Number: 504500
This article describes the use of 18-fluorodeoxyglucose (FDG) scans for the diagnostic evaluation of cancer patients. Since FDG is a positron emitting radio-pharmaceutical, a dedicated Positron Emission Tomography unit (PET) or a hybrid PET/SPECT (single photon emission computed tomography) unit is required for oncologic studies. As PET and PET/SPECT scanners become available to perform these images, it is important that knowledge regarding the usefulness of these images, and their limitations, be disseminated to health care providers. There are evolving uses of FDG scans; current use includes staging patients with non-small cell carcinoma of the lung, malignant melanoma, Hodgkin's disease, non-Hodgkin's lymphoma, colorectal carcinoma, and head and neck carcinoma.

Document emailed within 1 workday
Secure & encrypted payments

Bleeker-Rovers, C.P.; Vos, F.J.; Corstens, F.H.M.; Oyen, W.J.G. 2008: Imaging of infectious diseases using [18F] fluorodeoxyglucose PET Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 52(1): 17-29
Wang, R.-f.; Zhang, X.-m.; Zhang, C.-l.; Fu, Z.-l.; Fan, Y.; Cen, X.-n. 2004: The clinical application of 18F-fluorodeoxyglucose coincidence imaging in lymphoma Zhonghua Nei Ke Za Zhi 43(4): 284-287
Kalff, V.; Van Every, B.; Lambrecht, R.M.; Rowe, J.L.; Barton, H.J.; Leaney, P.; Jamieson, C.R.; Kelly, M.J. 1994: Planar cardiac F-18 fluorodeoxyglucose imaging with a conventional gamma camera Medical Journal of Australia 161(7): 413-417
Hoekstra, C.J.; Hoekstra, O.S.; Teengs, J.P.; Postmus, P.E.; Smit, E.F. 1999: Thoracic actinomycosis imaging with fluorine-18 fluorodeoxyglucose positron emission tomography Clinical Nuclear Medicine 24(7): 529-530
Stahl, A.; Weber, W.A.; Avril, N.; Schwaiger, M. 2000: Effect of N-butylscopolamine on intestinal uptake of fluorine-18-fluorodeoxyglucose in PET imaging of the abdomen Nuklearmedizin. Nuclear Medicine 39(8): 241-245
Nasseri, Y.; Ourian, A.J.; Waxman, A.; D'Angolo, A.; Thomson, L.E.; Margulies, D.R. 2012: Fluorodeoxyglucose positron emission tomography-computed tomography: a novel approach for the diagnosis of cholecystitis for equivocal diagnoses after ultrasound imaging American Surgeon 78(10): 1109-1113
Itoh, M.; Kikuchi, R.; Uruma, T.; Tsuji, T.; Kuroda, Y.; Watanabe, H.; Nakamura, H.; Aoshiba, K. 2014: All-in-one imaging of polymyositis, lung cancer and its metastatic lesions by fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography Acta Reumatologica Portuguesa 39(3): 283-284
Zhang, H-juan.; Zhan, F-hua.; Li, Y-jun.; Sun, H-ran.; Bai, R-ju.; Gao, S. 2011: Fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging of uterine leiomyosarcomas: 2 cases report Chinese Medical Journal 124(14): 2237-2240
Li, S.-j.; Guo, W.; Liao, J.-x.; Ren, G.-x. 2009: Evaluation of fluorodeoxyglucose-position-emission tomography-computer tomography imaging on head and neck squamous cell carcinomas including primary tumors and lymph node metastases Zhonghua Kou Qiang Yi Xue Za Zhi 44(10): 601-605
Akulina, E.A. 1998: The use of nuclear magnetic resonance imaging in oncology Klinichna Khirurhiia 5: 54
Arabi, M.; Piert, M. 2010: Hypoxia PET/CT imaging: implications for radiation oncology Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 54(5): 500-509
Tripathi, M.; Khurana, A.; D'Souza, M.M.; Sharma, R. 2009: Pitfall of (18)F-FDG-PET imaging in oncology: uterine fibromyoma Hellenic Journal of Nuclear Medicine 12(2): 175-176
Knapp, W.H. 1999: Guidelines for tumor diagnosis with (F-18)-fluorodeoxyglucose (FDG) Nuklearmedizin. Nuclear Medicine 38(6a): 267-269
Kubal, T.; Peabody, J.W.; Friedman, E.; Levine, R.; Pursell, S.; Letson, D.G. 2015: Using Vignettes to Measure and Encourage Adherence to Clinical Pathways in a Quality-Based Oncology Network: An Early Report on the Moffitt Oncology Network Initiative Managed Care 24(10): 56-64
Belhocine, T. 2003: The value of emission computed tomography with 18 F-fluorodeoxyglucose (PET scan with 18FDG) Jbr-Btr: Organe de la Societe Royale Belge de Radiologie 86(1): 23-25
Weber, W.A.; Dietlein, M.; Hellwig, D.; Kirsch, C.-M.; Schicha, H.; Schwaiger, M. 2003: PET with (18)F-fluorodeoxyglucose for staging of non-small cell lung cancer NUKLEARMEDIZIN. Nuclear Medicine 42(4): 135-144
Adam, Z.; Bolcák, K.; Stanícek, J.; Pour, L.; Hájek, R.; Krejcí, M.; Prásek, J.; Neubauer, J.; Mareschova, Y.; Vorlícek, J. 2006: The value of fluorodeoxyglucose positron emission tomography in multiple myeloma Vnitrni Lekarstvi 52(3): 207-214
Dizendorf, E.; Baumert, B.; von Schulthess, G.K.; Luetolf, U.M.; Steinert, H.C. 2001: The impact of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) on planning of radiotherapy Terapevticheskii Arkhiv 73(10): 11-14
Pipitone, N.; Versari, A.; Zuccoli, G.; Levrini, G.; Macchioni, P.; Bajocchi, G.; Salvarani, C. 2012: 18F-Fluorodeoxyglucose positron emission tomography for the assessment of myositis: a case series Clinical and Experimental Rheumatology 30(4): 570-573
Nakano, T.; Endo, S.; Mitsuda, S.; Endo, T.; Tezuka, Y.; Kanai, Y.; Otani, S.-i.; Yamamoto, S.-i.; Tetsuka, K.; Hasegawa, T.; Ishikawa, S.; Saito, N. 2012: Clinicopathological study of small lung cancer (diameter of 2 cm or less) by uptake value of 18F-fluorodeoxyglucose Kyobu Geka. Japanese Journal of Thoracic Surgery 65(1): 21-24